TY - JOUR
T1 - Advancing nephrology division leaders advise asn
AU - Braden, Gregory L.
AU - Chapman, Arlene
AU - Ellison, David H.
AU - Gadegbeku, Crystal A.
AU - Gurley, Susan B.
AU - Igarashi, Peter
AU - Kelepouris, Ellie
AU - Moxey-Mims, Marva M.
AU - Okusa, Mark D.
AU - Plumb, Troy J.
AU - Quaggin, Susan E.
AU - Salant, David J.
AU - Segal, Mark S.
AU - Shankland, Stuart J.
AU - Somlo, Stefan
N1 - Publisher Copyright:
© 2021 by the American Society of Nephrology.
PY - 2021
Y1 - 2021
N2 - New treatments, new understanding, and new approaches to translational research are transforming the outlook for patients with kidney diseases. A number of new initiatives dedicated to advancing the field of nephrology—from value-based care to prize competitions—will further improve outcomes of patients with kidney disease. Because of individual nephrologists and kidney organizations in the United States, such as the American Society of Nephrology, the National Kidney Foundation, and the Renal Physicians Association, and international nephrol-ogists and organizations, such as the International Society of Nephrology and the European Renal Association– European Dialysis and Transplant Association, we are beginning to gain traction to invigorate nephrology to meet the pandemic of global kidney diseases. Recognizing the timeliness of this opportunity, the American Society of Nephrology convened a Division Chief Retreat in Dallas, Texas, in June 2019 to address five key issues: (1) asserting the value of nephrology to the health system; (2) productivity and compensation; (3) financial support of faculty’s and divisions’ educational efforts; (4) faculty recruitment, retention, diversity, and inclusion; and (5) ensuring that fellowship programs prepare trainees to provide high-value nephrology care and enhance attraction of trainees to nephrology. Herein, we highlight the outcomes of these discussions and recommendations to the American Society of Nephrology.
AB - New treatments, new understanding, and new approaches to translational research are transforming the outlook for patients with kidney diseases. A number of new initiatives dedicated to advancing the field of nephrology—from value-based care to prize competitions—will further improve outcomes of patients with kidney disease. Because of individual nephrologists and kidney organizations in the United States, such as the American Society of Nephrology, the National Kidney Foundation, and the Renal Physicians Association, and international nephrol-ogists and organizations, such as the International Society of Nephrology and the European Renal Association– European Dialysis and Transplant Association, we are beginning to gain traction to invigorate nephrology to meet the pandemic of global kidney diseases. Recognizing the timeliness of this opportunity, the American Society of Nephrology convened a Division Chief Retreat in Dallas, Texas, in June 2019 to address five key issues: (1) asserting the value of nephrology to the health system; (2) productivity and compensation; (3) financial support of faculty’s and divisions’ educational efforts; (4) faculty recruitment, retention, diversity, and inclusion; and (5) ensuring that fellowship programs prepare trainees to provide high-value nephrology care and enhance attraction of trainees to nephrology. Herein, we highlight the outcomes of these discussions and recommendations to the American Society of Nephrology.
UR - http://www.scopus.com/inward/record.url?scp=85094957316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094957316&partnerID=8YFLogxK
U2 - 10.2215/cjn.01550220
DO - 10.2215/cjn.01550220
M3 - Article
C2 - 32792352
AN - SCOPUS:85094957316
SN - 1555-9041
VL - 16
SP - 319
EP - 327
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 2
ER -